CLINICAL_TRIALS
trial_result
· 2019-08-28
Clinical Trial Update: Can Pregabalin Reduce the Frequency and Severity of Dry Eye Symptoms After Laser-assisted in Situ Keratomileusis? [Phase 2, Phase 3]
Summary
A randomized trial investigating pregabalin to reduce frequency and severity of dry eye symptoms following LASIK; study completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Miami | Conditions: Dry Eye | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2019-08-28